Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.69, $0.50 better than the analyst estimate of $1.19. Revenue for the quarter came in at $510.4 million versus the consensus estimate of $526.16 million.

For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.

Earnings